Camp4 Secures $100 Million Series B Financing To Accelerate Expansion Of Its Novel Regulatory Rna-Targeting Platform And Advance Lead Programs Into The Clinic
Amount Raised
$100 Million
Round Type
Series B
CambridgeBiotechnologyHealth CareScience And EngineeringTherapeuticsBiopharmaDescription
CAMP4 Therapeutics, a biotechnology company harnessing the power of RNA to restore healthy protein expression, today announced the closing of a $100 million Series B round to advance the company’s lead regRNA programs and accelerate the expansion of the company’s regRNA Actuating Platform. Enavate Sciences, a portfolio company created by Patient Square Capital, led the round. Additional investors in the Series B financing include a large national managed care organization and the Gaingels, an LGBTQIA+/Allies investment syndicate supporting diversity in venture capital, along with other unnamed investors. Existing investors 5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group, and others also joined the round.
Quick answer
Camp4 Therapeutics Corp raised $100 Million in a Series B round, dated July 20, 2022. Camp4 Therapeutics Corp is based in Cambridge, Maryland, United States.
- How much did Camp4 Therapeutics Corp raise?
- Camp4 Therapeutics Corp raised $100 Million in a Series B round on July 20, 2022.
- What does Camp4 Therapeutics Corp do?
- At CAMP4, we are pioneering a novel approach to programmable therapeutics.
- Where is Camp4 Therapeutics Corp based and how big is it?
- Camp4 Therapeutics Corp is based in Cambridge, Maryland, United States.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Therapeutics around the same time
Companies in the same sectors as Camp4 Therapeutics Corp that raised within 45 days of this round, from Fundz verified event records.
- Theriva Biologics raised $3M (Seed) on July 29, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
- Kymera raised $150M (Post-IPO Equity) on August 19, 2022.
- AEON Biopharma raised $30M (Funding Round) on August 3, 2022.
- Renibus Therapeutics raised $15M on July 15, 2022.
Who to call at Camp4 Therapeutics Corp, and when
A new round usually means Camp4 Therapeutics Corp is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Camp4 Therapeutics Corp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Camp4 Therapeutics Corp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Camp4 Therapeutics Corp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Camp4 Therapeutics Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansCamp4 Therapeutics Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.